Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (139)

View All

Latest Posts

About This Stock More About This Stock
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Stocks Going Ex Dividend In February 2020
Article By: Fred Fuld
Saturday, February 1, 2020 3:03 PM EST
The following is a short list of some of the many stocks going ex dividend during the next month. Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’
In this article: AEP, ED, JNJ, SLB, SO, TGT, AMGN, IBKR, NLOK
Read
Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential
Article By: Benzinga
Friday, January 31, 2020 12:07 PM EST
Amgen, Inc.'s disappointing 2020 EPS guidance issued Thursday spooked investors, leading to a pullback in the stock.
In this article: AMGN
Read
Baird Downgrades Amgen To Underperform On Overdone 'Exuberance'
Article By: The Fly
Friday, January 31, 2020 7:57 AM EST
Baird analyst Brian Skorney downgraded Amgen to Underperform from Neutral with a price target of $185, up from $173.
In this article: AMGN
Read
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
Article By: Zacks Investment Research
Wednesday, January 22, 2020 4:00 PM EST
A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.
In this article: AZN, MRK, ALXN, AMGN, ABBV
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!

$AMGN

Comments Status Updates
July 2017 Stock Considerations
Dick Kaplan • 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments